Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-634
Closed -$632K 48
2026
Q1
$632K Sell
634
-20
-3% -$19.5K 0.22% 43
2025
Q4
$564K Sell
654
-30
-4% -$27.2K 0.18% 36
2025
Q3
$633K Hold
684
0.2% 38
2025
Q2
$677K Hold
684
0.23% 39
2025
Q1
$647K Sell
684
-4,297
-86% -$4.19M 0.25% 37
2024
Q4
$4.56M Buy
4,981
+38
+0.8% +$35.3K 1.58% 20
2024
Q3
$4.38M Sell
4,943
-10
-0.2% -$8.68K 1.58% 20
2024
Q2
$4.21M Sell
4,953
-142
-3% -$111K 1.56% 20
2024
Q1
$3.73M Hold
5,095
1.35% 24
2023
Q4
$3.36M Sell
5,095
-151
-3% -$89.5K 1.3% 28
2023
Q3
$2.96M Hold
5,246
1.29% 31
2023
Q2
$2.82M Buy
5,246
+272
+5% +$138K 1.27% 27
2023
Q1
$2.47M Buy
4,974
+724
+17% +$355K 1.21% 28
2022
Q4
$1.94M Buy
4,250
+75
+2% +$36.6K 1.14% 30
2022
Q3
$1.97M Sell
4,175
-203
-5% -$106K 1.18% 30
2022
Q2
$2.1M Sell
4,378
-2,253
-34% -$1.14M 1.13% 30
2022
Q1
$3.82M Buy
+6,631
New +$3.48M 1.5% 26

Other funds holding COST

Altrafin AG's COST Position: Q2 2026 in Review

Altrafin AG sold out of Costco (COST) in Q2 2026, closing a stake of 634 shares — an estimated $632K sold.

Altrafin AG first reported a position in COST in Q1 2022 and held it in 17 quarters. The position peaked at $4.56M in Q4 2024. 1,962 funds tracked by Wall St. Rank hold COST as of Q2 2026.

  • Altrafin AG reported no remaining Costco position as of Q2 2026 after selling out during the quarter.
  • Altrafin AG sold 634 Costco shares in Q2 2026, an estimated $632K.
  • Altrafin AG first reported a position in Costco in Q1 2022 and held it in 17 quarters.
  • Altrafin AG's Costco position peaked at $4.56M in Q4 2024.
  • 1,962 funds tracked by Wall St. Rank held Costco as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.